Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2013 1
2014 1
2015 1
2016 3
2017 4
2018 3
2019 4
2021 3
2022 6
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Cisko
Page 1
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.
Ben-Josef E, Guthrie KA, El-Khoueiry AB, Corless CL, Zalupski MM, Lowy AM, Thomas CR Jr, Alberts SR, Dawson LA, Micetich KC, Thomas MB, Siegel AB, Blanke CD. Ben-Josef E, et al. J Clin Oncol. 2015 Aug 20;33(24):2617-22. doi: 10.1200/JCO.2014.60.2219. Epub 2015 May 11. J Clin Oncol. 2015. PMID: 25964250 Free PMC article. Clinical Trial.
Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid.
Yang T, Dang Y, Ostaszewski B, Mengel D, Steffen V, Rabe C, Bittner T, Walsh DM, Selkoe DJ. Yang T, et al. Ann Neurol. 2019 Aug;86(2):215-224. doi: 10.1002/ana.25513. Epub 2019 Jun 22. Ann Neurol. 2019. PMID: 31168802 Free PMC article. Clinical Trial.
METHODS: We developed an ultrasensitive immunoassay and used it to measure oAbeta in cerebrospinal fluid (CSF) from 104 AD subjects participating in the ABBY and BLAZE phase 2 trials of the anti-Abeta antibody crenezumab. ...
METHODS: We developed an ultrasensitive immunoassay and used it to measure oAbeta in cerebrospinal fluid (CSF) from 104 AD subjects particip …
National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine.
Pelet Del Toro N, Yahia R, Feldman SR, Van Voorhees A, Green L, Schwartzman S, Siegel E, Cordoro KM, Desai SR, Kircik L, Liao W, Hawkes JE, Weinberg J, Koo J, Wallace EB, Howard LM, Armstrong A, Han G. Pelet Del Toro N, et al. JAAD Int. 2023 Apr 5;12:32-36. doi: 10.1016/j.jdin.2023.02.018. eCollection 2023 Sep. JAAD Int. 2023. PMID: 37274387 Free PMC article.
ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease.
Cummings JL, Cohen S, van Dyck CH, Brody M, Curtis C, Cho W, Ward M, Friesenhahn M, Rabe C, Brunstein F, Quartino A, Honigberg LA, Fuji RN, Clayton D, Mortensen D, Ho C, Paul R. Cummings JL, et al. Neurology. 2018 May 22;90(21):e1889-e1897. doi: 10.1212/WNL.0000000000005550. Epub 2018 Apr 25. Neurology. 2018. PMID: 29695589 Free PMC article. Clinical Trial.
Quality of Life in Adolescents and Young Adults: The Role of Symptom Burden.
Steineck A, Bradford MC, O'Daffer A, Fladeboe KM, O'Donnell MB, Scott S, Yi-Frazier JP, Rosenberg AR. Steineck A, et al. J Pain Symptom Manage. 2022 Sep;64(3):244-253.e2. doi: 10.1016/j.jpainsymman.2022.05.017. Epub 2022 May 29. J Pain Symptom Manage. 2022. PMID: 35649460 Free PMC article.
30 results